SCHEMBL556529

SCHEMBL556529

CCC(C)(C(C)=O)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.38
ALDH1A1 P00352 3/20 0.35
GAA P10253 3/20 0.33
MGAM O43451 2/20 0.33
SI P14410 2/20 0.33
MGAM2 Q2M2H8 2/20 0.33
POLB P06746 1/20 0.33
MMP8 P22894 1/20 0.32
PKM P14618 2/20 0.31
KDM4E B2RXH2 1/20 0.31
TSHR P16473 3/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
ATM Q13315 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
THRB P10828 1/20 0.31
KCNN4 O15554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327259 0.87 DGAT1 (0.42) DGAT1ALDH1A1GAAMGAMSI
SCHEMBL9752808 0.83 DGAT1 (0.39) DGAT1ALDH1A1POLBMMP8TSHR
SCHEMBL4791578 0.81 DGAT1 (0.38) DGAT1ALDH1A1POLBMMP8TSHR
SCHEMBL17617189 0.80 ALDH1A1 (0.36) DGAT1ALDH1A1GAAMGAMSI
SCHEMBL17617140 0.80 ALDH1A1 (0.36) DGAT1ALDH1A1GAAMGAMSI
SCHEMBL6229413 0.79 TSHR (0.37) DGAT1ALDH1A1GAAMGAMSI
SCHEMBL3169320 0.79 DGAT1 (0.37) DGAT1ALDH1A1POLBMMP8TSHR
SCHEMBL2316349 0.79 MMP8 (0.47) ALDH1A1GAAMGAMSIMGAM2
SCHEMBL8899156 0.79 TSHR (0.37) DGAT1ALDH1A1GAAMGAMSI
SCHEMBL13051348 0.79 ALDH1A1 (0.39) ALDH1A1GAATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2419407-B1 IMPROVED PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF PHARMATHEN SA (GR) 2012-11-14 EP disclosed
EP-2419407-A1 IMPROVED PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF Pharmathen S.A. (GR) 2012-02-22 EP disclosed
US-20120035374-A1 PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF PHARMATHEN S.A. (GR) 2012-02-09 US disclosed
WO-2010118757-A1 IMPROVED PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF PHARMATHEN S.A. (GR) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035374-A1 PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF HMGCR, CETP, PCSK9 DGAT1 1283/4885ALDH1A1 2713/4885GAA 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.